Education
About Us
Working with TipRanks
Follow Us
MedPlus Health Services Ltd. (IN:MEDPLUS)
:MEDPLUS
MEDPLUS Stock Chart & Stats
₹808.80
₹1.40(0.17%)
At close: 4:00 PM EST
₹808.80
₹1.40(0.17%)
Day’s Range― - ―
52-Week Range₹603.00 - ₹1,052.05
Previous CloseN/A
Volume104.47K
Average Volume (3M)39.52K
Market Cap
₹100.98B
Enterprise Value₹120.33B
Total Cash (Recent Filing)₹3.67B
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)41.8
Beta0.54
Next Earnings
Jun 02, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)5.30
Shares Outstanding120,054,640
10 Day Avg. Volume11,750
30 Day Avg. Volume39,524
Financial Highlights & Ratios
PEG Ratio0.46
Price to Book (P/B)5.18
Price to Sales (P/S)1.47
P/FCF Ratio18.21
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
₹1,155.00Price Target Upside42.80% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)17.16
Revenue Forecast (FY)₹68.47B
Bulls Say, Bears Say
Bulls Say
Omnichannel + Store NetworkA large branded-store footprint combined with omnichannel ordering and home delivery creates a durable competitive advantage: it captures repeat chronic prescriptions, broadens catchment beyond walk-ins, raises throughput per store and supports cross-selling, sustaining revenue resilience over months.
Material Free Cash Flow GenerationStrong free cash flow transformation provides lasting financial optionality: it funds store rollouts, technology, and working capital internally, enables debt paydown or strategic investments, and cushions the business against cyclical headwinds without reliance on external financing.
Balanced Capital Structure & Improving ROEModerate leverage and a strong equity base combined with improving ROE signal disciplined capital allocation. This balance supports sustainable investment, preserves financial flexibility for growth initiatives, and indicates management effectiveness in generating shareholder returns.
Bears Say
Gross Margin CompressionA material decline in gross margins is a durable risk: it narrows underwriting buffer against rising procurement, logistics or wage costs and limits ability to expand operating margins. Unless cost structure or product mix improves, profitability remains vulnerable to small shocks.
Rising Total Debt TrendAn upward trend in total debt, even from a moderate base, can constrain financial flexibility over time. Higher interest or refinancing needs reduce free cash available for reinvestment and make growth or margin recovery plans more sensitive to cash flow variances.
Thin Net Profit MarginsA low net margin (~2.45%) leaves limited room for error: small cost increases or pricing pressure can quickly erode profitability. Sustained low margins limit internally generated funds for expansion and increase dependence on operational improvements to justify growth.
MedPlus Health Services Ltd. News
MEDPLUS FAQ
What was MedPlus Health Services Ltd.’s price range in the past 12 months?
MedPlus Health Services Ltd. lowest stock price was ₹603.00 and its highest was ₹1052.05 in the past 12 months.
What is MedPlus Health Services Ltd.’s market cap?
MedPlus Health Services Ltd.’s market cap is ₹100.98B.
When is MedPlus Health Services Ltd.’s upcoming earnings report date?
MedPlus Health Services Ltd.’s upcoming earnings report date is Jun 02, 2026 which is in 85 days.
How were MedPlus Health Services Ltd.’s earnings last quarter?
MedPlus Health Services Ltd. released its earnings results on Jan 30, 2026. The company reported ₹5.3 earnings per share for the quarter, beating the consensus estimate of ₹4.8 by ₹0.5.
Is MedPlus Health Services Ltd. overvalued?
According to Wall Street analysts MedPlus Health Services Ltd.’s price is currently Undervalued.
Does MedPlus Health Services Ltd. pay dividends?
MedPlus Health Services Ltd. does not currently pay dividends.
What is MedPlus Health Services Ltd.’s EPS estimate?
MedPlus Health Services Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does MedPlus Health Services Ltd. have?
MedPlus Health Services Ltd. has 120,054,640 shares outstanding.
What happened to MedPlus Health Services Ltd.’s price movement after its last earnings report?
MedPlus Health Services Ltd. reported an EPS of ₹5.3 in its last earnings report, beating expectations of ₹4.8. Following the earnings report the stock price went up 3.697%.
Which hedge fund is a major shareholder of MedPlus Health Services Ltd.?
Currently, no hedge funds are holding shares in IN:MEDPLUS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
MedPlus Health Services Ltd.
MedPlus Health Services Limited engages in the retail trading of medicines and general items in India. It offers pharmaceutical and wellness products, including medicines, vitamins, medical devices, and test kits; fast-moving consumer goods, such as toiletries, baby care products, soaps, detergents, and sanitizers. The company also provides wholesale cash and carry, and pathological laboratory testing services, as well as engages in the contract manufacturing of private label pharmaceuticals. As of March 31, 2021, it operated through 1,659 stores located in the states of Karnataka, Tamil Nadu, Telangana, and Andhra Pradesh, as well as through its online store. The company was incorporated in 2006 and is based in Hyderabad, India.
MEDPLUS Stock 12 Month Forecast
Average Price Target
₹1,155.00
▲(42.80% Upside)
Technical Analysis
HealthCare Global Enterprises Ltd.
―
Indoco Remedies Limited
―
Dr. Lal PathLabs Limited
―
Metropolis Healthcare Ltd.
―
Vijaya Diagnostic Centre Ltd.
―